Cargando…
Molecular based newborn screening in Germany: Follow-up for cystinosis
BACKGROUND: Newborn screening (NBS) programs for treatable metabolic disorders have been enormously successful, but molecular-based screening has not been broadly implemented so far. METHODS: This prospective pilot study was performed within the German NBS framework. DNA, extracted from dried blood...
Autores principales: | Hohenfellner, Katharina, Bergmann, Carsten, Fleige, Tobias, Janzen, Nils, Burggraf, Siegfried, Olgemöller, Bernd, Gahl, William A., Czibere, Ludwig, Froschauer, Sonja, Röschinger, Wulf, Vill, Katharina, Harms, Erik, Nennstiel, Uta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796768/ https://www.ncbi.nlm.nih.gov/pubmed/31641587 http://dx.doi.org/10.1016/j.ymgmr.2019.100514 |
Ejemplares similares
-
Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
por: Vill, Katharina, et al.
Publicado: (2021) -
One Year of Newborn Screening for SMA – Results of a German Pilot Project
por: Vill, Katharina, et al.
Publicado: (2019) -
Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening – Opportunity or Burden?(1)
por: Müller-Felber, Wolfgang, et al.
Publicado: (2020) -
Newborn Screening: Review of its Impact for Cystinosis
por: Hohenfellner, Katharina, et al.
Publicado: (2022) -
Patients With Infantile Nephropathic Cystinosis in Germany and Austria: A Retrospective Cohort Study
por: O'Connell, Nina, et al.
Publicado: (2022)